← Back to Search

Exercise for Anxiety Disorders

Led By Kristin Szuhany, MD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Primary diagnosis of a DSM-5 anxiety disorder (generalized anxiety disorder, panic disorder, social anxiety disorder)
Males and females ages 18-60
Screening 3 weeks
Treatment Varies
Follow Up day 2 visit
Awards & highlights

Study Summary

This trial will study whether exercise can help people with high levels of anxiety and anxiety disorders by improving their ability to learn and remember things.

Who is the study for?
This trial is for adults aged 18-60 with a primary diagnosis of an anxiety disorder (generalized, panic, or social) and high anxiety sensitivity. Participants must be able to exercise safely and not be pregnant, using benzodiazepines, or have recent substance abuse issues. Stable psychiatric medication use for at least 4 weeks prior is required.Check my eligibility
What is being tested?
The study compares the effects of physical activity versus sitting on fear learning in people with high anxiety sensitivity and disorders. It looks into how these activities affect their expectations, emotions, and stress responses after learning to overcome fear.See study design
What are the potential side effects?
Since this trial involves exercise as an intervention, potential side effects may include typical risks associated with physical activity such as muscle strain or injury. Sitting has minimal risk but may involve discomfort from remaining stationary.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
I have been diagnosed with an anxiety disorder like GAD, panic, or social anxiety.
I am between 18 and 60 years old.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 2 visit
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 2 visit for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Heart rate (HR)
Skin Conductance Response (SCR)

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Exercise GroupExperimental Treatment1 Intervention
Participants who will be randomized to moderate intensity exercise after extinction (Day 1)
Group II: Seated groupPlacebo Group1 Intervention
Participants who will be randomized to sitting after extinction (Day 1)
First Studied
Drug Approval Stage
How many patients have taken this drug
Completed Phase 1

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,367 Previous Clinical Trials
839,711 Total Patients Enrolled
Kristin Szuhany, MDPrincipal InvestigatorNYU Langone Health

Media Library

Exercise Clinical Trial Eligibility Overview. Trial Name: NCT05203731 — N/A
Social Anxiety Disorder Research Study Groups: Exercise Group, Seated group
Social Anxiety Disorder Clinical Trial 2023: Exercise Highlights & Side Effects. Trial Name: NCT05203731 — N/A
Exercise 2023 Treatment Timeline for Medical Study. Trial Name: NCT05203731 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current participant count of this clinical investigation?

"Affirmative. Clinicaltrials.gov verifies that this trial, which was initially announced on November 14th 2022, is actively recruiting patients. The protocol requires 50 participants to be enrolled at a single site."

Answered by AI

Is enrollment available for this trial at the present time?

"This research project seeks to include 50 individuals who are between 18 and 60 years old, present with panic attacks, have an Anxiety Sensitivity Index-3 score of at least 23 (corresponding to high anxiety sensitivity), suffer from a DSM-5 specified anxiety disorder such as generalized anxiety disorder or social anxiety disorder, and provide informed consent."

Answered by AI

Are elderly individuals, over 75 years of age, able to participate in this medical research?

"This trial is open to participants between 18 and 60 years old. However, there are 326 medical studies available for minors and 828 clinical trials catered towards seniors."

Answered by AI

Is enrollment for this experiment currently available?

"Per the data posted on clinicaltrials.gov, this medical investigation is in its participant recruitment phase. The study was first released on November 14th 2022 and recently updated to reflect current information."

Answered by AI

Who else is applying?

What state do they live in?
New York
What site did they apply to?
NYU Langone Health
What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?

What questions have other patients asked about this trial?

Am I allowed to take Tylenol? Allegra? Ibuprofen during this study?
PatientReceived 2+ prior treatments

Why did patients apply to this trial?

Seeking a new alternative to my anxiety.
PatientReceived 2+ prior treatments
~20 spots leftby Jan 2025